Natural History of Paroxysmal Nocturnal Hemoglobinuria

Peter Hillmen(Leeds Teaching Hospitals NHS Trust), J. V. Dacie(Hammersmith Hospital), Monica Bessler(Memorial Sloan Kettering Cancer Center), Lucio Luzzatto(Muhimbili University of Health and Allied Sciences), S. M. Lewis(Hammersmith Hospital)
New England Journal of Medicine
November 9, 1995
10.1056/nejm199511093331904
Cited by 900

Related Papers

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
|Blood|2008|3.2k
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k